CDK1 and breast carcinoma: An increased expression of inhibitory phosphorylation of Cdc2 at Tyr15 and decreased expression of Cdc2 and CyclinB1 were observed by TAIII (Figures 1B,C, 3), indicating that TAIII induces the G2/M phase arrest by inhibiting the formation of MPF in breast cancer cells.